Acorda Therapeutics
ACOR
#10086
Rank
HK$6.39 M
Marketcap
HK$5.15
Share price
0.00%
Change (1 day)
-95.65%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -HK$2.13 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are HK$0.11 Billion. In 2023 the company made an earning of -HK$2.06 Billion a decrease over its 2022 earnings that were of -HK$41.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$2.13 Billion3.24%
2023 -HK$2.06 Billion4848.63%
2022 -HK$41.56 Million-93.25%
2021 -HK$0.62 Billion2.52%
2020 -HK$0.61 Billion-69.45%
2019 -HK$1.97 Billion-700.62%
2018 HK$0.32 B-118.02%
2017 -HK$1.82 Billion805.99%
2016 -HK$0.21 Billion-173.88%
2015 HK$0.27 B-6.58%
2014 HK$0.29 B20.19%
2013 HK$0.24 B18.7%
2012 HK$0.20 B-26.54%
2011 HK$0.27 B
2009 -HK$0.64 Billion10.65%
2008 -HK$0.58 Billion86.17%
2007 -HK$0.31 Billion68.1%
2006 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.16 B-107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.04 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.67 Billion-68.58%๐Ÿ‡ฉ๐Ÿ‡ช Germany
HK$0.48 B-122.89%๐Ÿ‡บ๐Ÿ‡ธ USA